What is CNS disease?
Central Nervous System (CNS) disease refers to a broad category of medical conditions that affect the brain and spinal cord, which together comprise the central nervous system.
November 8, 2023
by ChatGPT/PharmaSources
AHA News: Statistics Report Offers Snapshot of the Nation's Brain Health – And a Guide to Protecting It
Brain diseases, including Alzheimer's disease and other forms of dementia, are closely connected to heart health.
January 26, 2022
by drugs.com
Keeping Weight Stable Could Help Save Your Brain
Older adults who maintain a steady weight as they age are less likely to experience rapid cognitive decline...
January 25, 2022
by drugs.com
Researchers identify new genetic clues for ‘silent’ strokes
New research has discovered genetic clues in people who have had small, ‘silent’ strokes that could enable the development of new treatments for the condition.
March 29, 2021
by pharmatimes
Salbutamol significantly increases cerebral perfusion in proof-of-concept trial
In the Phase I trial, the beta-2 adrenoceptor agonist salbutamol significantly increased cerebral perfusion, a key biomarker in neurodegenerative disease.
March 17, 2021
by europeanpharmaceuticalreview
Scientists at IIT Madras identify energy deficiency in brain cells as major cause for Parkinson’s Disease
The novel findings of this research may enhance understanding of the pathophysiology of Parkinson’s Disease and might finally lead to a cure.
March 11, 2021
by expresspharma
Parkinson’s UK invests £1.2m in drug design project
Charity organisation Parkinson’s UK has announced it will fund up to £1.2m into a one-year drug design project in partnership with the University of Sheffield.
March 10, 2021
by pharmatimes
OncoSynergy Announces First Patient Treated in OS2966 Trial of Recurrent Glioblastoma
OncoSynergy announced the first patient was treated in the Company's First-in-Human Phase 1 clinical trial evaluating OS2966 for the treatment of recurrent glioblastoma at Moffitt Cancer Center in Tampa, Florida.
March 10, 2021
by americanpharmaceuticalreview
Alterity Therapeutics announces funding from Michael J. Fox Foundation for ATH434 dose optimization for Parkinson's disease clinical trials
Alterity Therapeutics has announced the award of a grant from The Michael J. Fox Foundation for Parkinson's Research to determine optimal dosing of its lead drug candidate ATH434 for Parkinson's disease (PD) based on imaging of brain iron.
February 10, 2021
by prnasia
New system could deliver schizophrenia medicine directly to brain
A team has created a nasal spray as a drug delivery system to get schizophrenia medication directly to the brain.
January 20, 2021
by europeanpharmaceuticalreview
Therapeutic Solutions Files Patent Application for Mechanism of Mesenchymal Stem Cell Treatment
Therapeutics Solution International announced the filing of a patent application covering novel findings demonstrating enhancement of blood brain barrier integrity subsequent to traumatic brain injury.
November 6, 2020
by americanpharmaceuticalreview
Fondazione Prada Presents "Human Brains," A Multidisciplinary Project Dedicated To Brain Studies
"Human Brains" is a multidisciplinary project dedicated to brain studies taking place from November 2020 to November 2022.
October 16, 2020
by prnasia